Is aripiprazole a key to unlock anorexia nervosa?: A case series

Basit Öğe Kaydı
dc.contributor.authorTahillioglu, Akin
dc.contributor.authorOzcan, Tugce
dc.contributor.authorYuksel, Gamze
dc.contributor.authorMajroh, Noorjahan
dc.contributor.authorKose, Sezen
dc.contributor.authorOzbaran, Burcu
dc.date.accessioned2020-12-01T11:58:07Z
dc.date.available2020-12-01T11:58:07Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstractAripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side-effect profile; but it is not enough to cure comorbid depressive symptoms in AN.en_US
dc.identifier.doi10.1002/ccr3.3271
dc.identifier.issn2050-0904
dc.identifier.issn2050-0904en_US
dc.identifier.scopus2-s2.0-85090211910en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org/10.1002/ccr3.3271
dc.identifier.urihttps://hdl.handle.net/11454/61931
dc.identifier.wosWOS:000566280300001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofClinical Case Reportsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectanorexia nervosaen_US
dc.subjectaripiprazoleen_US
dc.subjectBMIen_US
dc.subjectcase seriesen_US
dc.subjectdepressionen_US
dc.subjectfollow-upen_US
dc.subjecttreatmenten_US
dc.titleIs aripiprazole a key to unlock anorexia nervosa?: A case seriesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu